2026
Immunotherapy with a short-lived anti-PD-L1 antibody in Alzheimer’s disease: a phase 1b, randomized, double-blind trial. Nature Medicine 32: 3458-3465.
Croese T, Mummery CJ, Bregman N, Bracha D, Baruch K, Kertser A, Raveh S, Shochat E, Schwartz M.
Alzheimer’s disease causes bone marrow myelopoiesis dysfunction. Nat Neurosci: September 08, 2026.
Abellanas MA, Basurco L, Purnapatre M, Burgaletto C, Castellani G, Phoebeluc Colaiuta S, Peralta-Ramos JM, Ibraheem A, Murad S, Antonello P, Kovacs M, Androsova Y, Nathansohn B, Partney H, Cahalon L, Valdes-Mas R, Josephides JM, Salame TM, Espelosin M, Cuadrado-Tejedor M, Garcia-Osta A, Deczkowska A, Schwartz M.
Disruption of the Brain-Spleen Axis Impairs Monocyte-Microglia Communication and Accelerates Disease Progression in a Model of Amyloidosis. Nat Commun: Jun 19, 2026.
Croese T, Abellanas, M.A., Polonsky, H., Arad, M., Ramos, J. M. P., Androsova, Y., Riccitelli, S., Medina, S., Palmas, F., Strobel, R., Castellani, G., Kviatcovsky, D., Phoebeluc-Colaiuta, S., Adam, M., Murad, S., Partney, H., Kitsberg, D., Dieter, A., Salame, T. M., Brandis, A., Mehlman, T., Singer, O., Rivlin-Etzion, M., Wiegert, S., Shaul, Y., Kobiler, O., Yizhar, O., Habib, N., Schwartz, M.
Evolving brain-immunity: From Ramón y Cajal’s mysterious butterflies to a garden sustained by immune cells as their nectar. Neuron 114: 1712-5.
Opinion: Schwartz M.
Treating the immune system to repair the brain. Sci Transl Med 18: eaeb1677.
Opinion: Schwartz M, Croese T.